Armistice Capital, LLC 13D and 13G filings for FibroGen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 3:27 pm Purchase | 2025-03-31 | 13G | FibroGen, Inc. FGEN | Armistice Capital, LLC | 340,000 8.420% | 68,000 (+25.00%) | Filing |
| 2025-02-14 5:49 pm Unchanged | 2024-12-31 | 13G | FibroGen, Inc. FGEN | Armistice Capital, LLC | 272,000 6.750% | 0 (Unchanged) | Filing |
| 2024-11-14 4:52 pm Sale | 2024-09-30 | 13G | FibroGen, Inc. FGEN | Armistice Capital, LLC | 272,000 6.770% | -118,560 (-30.36%) | Filing |
| 2024-02-14 3:37 pm Purchase | 2023-12-31 | 13G | FibroGen, Inc. FGEN | Armistice Capital, LLC | 390,560 9.930% | 390,560 (New Position) | Filing |